Apr 13, 2019
Chimeric antigen receptor T cell (CAR-T) otherwise known as engineering T cell immunotherapy and T cell receptor T cell (TCR-T) has emerged as a viable therapeutic strategy for treating tumors.
2. 10:01 AM
Color Professionals Choose "Chinese Porcelain" as 2020's Color of the Year
4. 09:48 AM
A 131-Foot Asteroid Might Hit The Earth -- But There’s No Need To Worry